Wang Shujun Lou Lili Yang Lei Wang Feng Zhan Hefeng
10.3389/fphar.2022.854277
Front Pharmacol
2022 Apr 5;13:854277.
non-small-cell lung carcinoma (nsclc) aumolertinib drug-induced colitis epidermal growth factor receptor tyrosine kinase inhibitor intestinal haemorrhage osimertinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/35479327/
Case Reports
PMC9037232
35479327
Intestinal Haemorrhage and Colitis Induced by Treatment With Osimertinib for Non-Small-Cell Lung Carcinoma: A Case Report
2022